Opening early July at Westfield London. Register your interest to be first to know. Email us

Navigating UK healthcare

Managing long-term conditions across NHS and private care

A long-term condition in the UK is usually best managed by the NHS, with occasional private additions where they fit. This article sets out how to use both sides of the system well over years rather than weeks.

SR

Dr Seth Rankin

MBChB MRCGP. Founder of LoveMyLife. Former NHS Commissioner and Managing Partner of Wandsworth Medical Centre.

23 April 2026 · 8 min read
Managing long-term conditions across NHS and private care

A long-term condition in the UK (diabetes, hypertension, heart disease, asthma, inflammatory arthritis, epilepsy, depression, and many others) is typically managed across a long time horizon, through a combination of primary-care review, specialist input at specific points, medication, monitoring, and lifestyle interventions. Almost all of this is delivered through the National Health Service (NHS), at no cost to the patient beyond prescription charges where applicable.

Private care has a specific supplementary role for some patients at some points. This article sets out how long-term-condition management works in the NHS, where private care can add value without replacing the NHS, and how to use the two sides well over years. Sources are at the end.

Why the NHS is the right main route for long-term conditions

Several features of long-term-condition management make the NHS the right primary home.

  • Continuity of record. A long-term condition is tracked through a medical record that spans years or decades. The NHS medical record, held by your GP and shared with your NHS specialists, is the long-term document.

  • NICE-approved treatments. Many high-cost long-term-condition medications (biologics for inflammatory arthritis, GLP-1 medication for defined obesity criteria, direct-acting antivirals, specialist mental-health drugs) are funded on the NHS at no cost to the patient under NICE technology appraisals. Buying the same medication privately can run to hundreds or thousands of pounds per month.

  • National chronic-disease management programmes. The NHS runs structured programmes for diabetes, hypertension, heart failure, asthma, COPD, and others through general practice under the Quality and Outcomes Framework (QOF). These include regular reviews, monitoring, and proactive recall.

  • National screening integration. Long-term-condition patients are often at higher risk of complications; the NHS co-ordinates screening invitations and monitoring across specialties.

  • Co-ordinated specialist-generalist shared care. Most specialist-initiated long-term-condition treatment is continued by the NHS GP under a shared-care agreement (see the shared care article).

These features are difficult to replicate in private care, which is typically organised around episodes rather than decades.

The standard NHS long-term-condition pathway

For most long-term conditions, the pathway looks like this.

  • Diagnosis. A GP recognises the pattern, does initial tests, and either confirms the diagnosis or refers to a specialist for confirmation.

  • Specialist assessment (for conditions that need it): a hospital outpatient clinic, confirming diagnosis, initiating specialist treatment if needed, and writing a management plan back to the GP.

  • Shared-care transfer. The specialist and the GP agree a shared-care protocol. Ongoing prescribing and monitoring move to the GP, with the specialist available for advice and re-referral.

  • Annual review. The GP runs a structured review covering medication, monitoring tests, blood pressure, weight, mental health, and relevant lifestyle factors.

  • Medication review. Periodic reconciliation of medications by the GP or practice pharmacist, looking for interactions, side effects, or drugs that could be stopped.

  • Escalation as needed. If the condition changes, the GP re-refers to the specialist. Most long-term conditions stay stable under GP review for years at a time.

This is the structure NHS general practice is designed around. It is what much of the QOF framework pays for, and it is the core clinical work of NHS primary care.

Where private care fits alongside

Private care can add value at specific points in a long-term-condition journey without replacing the NHS-based structure.

  • A private consultation to accelerate diagnosis. If an initial NHS referral is facing a long wait, a private specialist consultation can produce an earlier diagnostic answer. The letter is brought back to the NHS GP for onward NHS-funded management.

  • A private diagnostic test (MRI, CT, blood panel) on demand. Quicker access to specific diagnostic tests. Useful where the test is the bottleneck. Results are handed to the NHS GP.

  • A second opinion on a specific treatment choice. A private specialist consultation can give a second opinion on a contested treatment decision without changing the NHS-funded pathway.

  • A longer consultation when the NHS ten-minute slot is not enough. Private generalist consultations (30 to 60 minutes) can give time to map a complex picture together.

  • A specific non-NHS treatment. Some treatments (cosmetic dermatology, some aesthetic work, specific fertility options) are not NHS-funded; private is the route when these are the right clinical fit.

  • Access during a period of NHS access pressure. When NHS primary care access is stretched, an occasional private GP consultation can bridge the gap.

In each case, the private contact is episodic, adds something specific, and hands back to the NHS for the ongoing work. None of these uses private care as a substitute for NHS long-term-condition management.

Where private care is usually not the right route

Several situations where private care is usually not a good primary choice for long-term-condition work.

  • Ongoing prescribing of expensive specialist medication. Biologics, some ADHD medication, some specialist mental-health drugs, and other high-cost treatments are NHS-funded under NICE guidance. Paying privately for the same treatment can run to thousands of pounds per month, and the NHS route is equally clinically valid.

  • Routine chronic-disease monitoring. Annual diabetic reviews, blood-pressure monitoring, asthma reviews, and other structured QOF-funded NHS reviews are comprehensive and free. Paying privately for these produces a nicer appointment experience but not a better clinical outcome.

  • Hospital inpatient care for acute complications. If a long-term condition decompensates and needs hospital admission, the NHS is the right place. Private hospitals typically do not have the intensive-care capacity or critical-care infrastructure for acute decompensation, as covered in the complexity backstop article.

  • Urgent or unplanned care. Same reason. The NHS is the urgent-care system; private is for planned work.

Practical patterns that work well

A few patterns that tend to produce good long-term outcomes.

  • NHS GP as the long-term co-ordinator. Your GP is the clinician who will see you through the whole arc of the condition. Investing in the GP relationship pays off over years.

  • NHS specialist for the specialty-specific parts. Confirmed diagnosis, specialist medication initiation, specialist review when needed.

  • Shared care for ongoing prescribing. The efficient mechanism that keeps specialist expertise linked to GP continuity.

  • Occasional private contacts where they add something specific. A private scan, a second opinion, a longer consultation. Each one ends with a letter to the NHS GP.

  • Active use of the NHS App. Repeat prescriptions, appointments, test results, records. The NHS App makes the long-term relationship substantially easier.

  • A written list of medications and a written summary of the condition. Useful for your own reference, useful for every new clinician you see, useful if you travel, and useful if you move practice.

What can go wrong, and how to avoid it

A few specific failure modes that crop up repeatedly.

  • Fragmented records. A patient with NHS care, private consultations, and online private pharmacy prescribing can end up with a fragmented record across several systems. Mitigated by insisting every private contact writes to the NHS GP.

  • Medication duplication or interaction. Different clinicians prescribing in parallel can produce double dosing or interactions. Mitigated by having the NHS GP as the reconciling single point.

  • Loss of specialist contact. A specialist contact can go quiet after the initial episode, leaving the patient and GP without a named specialist to refer back to. Mitigated by getting the specialist's secretary email address at the point of discharge back to shared care.

  • Delayed escalation. A long-term-condition patient can be slow to escalate a deterioration, especially if the NHS GP is difficult to reach. Mitigated by knowing the urgent-care routes (NHS 111, urgent treatment centres, A&E if needed).

None of these is a reason to choose private over NHS, or NHS over private. They are reasons to keep the NHS GP relationship central and to use private care as an occasional add-on.

The summary

Long-term conditions in the UK are best managed with the NHS as the main route and private care as an occasional supplement. The NHS GP is the long-term co-ordinator, the NHS specialist does the specialty-specific work, shared care joins the two, and NICE-approved treatments become available to the whole population without private fees.

Private care adds value at specific points (a quicker diagnostic answer, a longer consultation, a specific non-NHS treatment, a second opinion). It is not usually the right primary home for a long-term condition.

The combination of NHS for the spine of care and private for defined additions tends to produce better long-term outcomes than using either alone.

Sources and further reading

Clinically reviewed

Dr Seth Rankin · MBChB MRCGP - Founder and Medical Director, LoveMyLife

About the author

Dr Seth Rankin qualified in medicine at Auckland School of Medicine in New Zealand in 1990 and worked as a junior doctor across New Zealand, Australia, and the UK before qualifying as a Member of the Royal College of General Practitioners (MRCGP) through the London Deanery in 2004. He was Managing Partner of Wandsworth Medical Centre from 2006 to 2016 and served as a Board Member of Wandsworth Clinical Commissioning Group for nine years. He is the founder of London Travel Clinic, London Doctors Clinic, London Medical Laboratory, and LoveMyLife.

Read more about Dr Seth Rankin.

Ready to start?

If you would like to discuss how NHS and private care might work together for your specific long-term condition, the next step is to book.

Begin your consultation at this link. Online or in person at Westfield London.